GLO1 and diabetes mellitus: Therefore, increasing the expression of Glo1, as recently demonstrated in an randomized, placebo-controlled crossover clinical trial with trans-resveratrol and hesperetin, [12], can be an important new tool to prevent diabetes-induced impaired arteriogenesis.